RespondHealth and Microsoft collaborate to deliver AI-driven insights from EHR data

The partnership will leverage advanced AI techniques and continuously updated electronic health record (EHR) data to enable health and life science companies optimize performance, evaluate treatments, and improve patient outcomes.

RespondHealth, a real-world evidence (RWE) clinical discovery company, has announced a partnership with Microsoft to advance healthcare and life sciences (HLS) analytics. By The company will integrate their extensive real-world health datasets with Microsoft Azure OpenAI Service to deliver AI-powered solutions that simplify data analysis and accelerate decision-making across the sector. This integration will enable HLS organizations to evaluate pharmaceutical efficacy, identify specific patient cohorts for clinical trials, analyze market trends, and develop strategies to optimize performance.

Jason Graefe, Corporate Vice President of ISV & Digital Natives at Microsoft, highlighted the transformative potential of the partnership.

“RespondHealth’s integration of Azure OpenAI Service and other advanced Azure solutions demonstrates how data-driven Digital Natives can transform healthcare. Microsoft Azure offers a secure and scalable foundation for RespondHealth to develop its analytics platform, providing insights to enhance patient outcomes. With advancements in AI, the platform can now leverage machine learning algorithms to predict patient trends, personalize treatment plans, and improve overall healthcare management.”

One of the first use cases resulting from this partnership is the GLP-1 Knowledge Graph (KG). Focused on patients using injectable GLP-1 therapies, this platform aims to demonstrate the scalability and versatility of RespondHealth’s analytics tools. The GLP-1 KG will use Azure OpenAI Service and other advanced Azure AI solutions, such as large language models (LLMs), to make data exploration more accessible. Its conversational, plain-language interface allows users to navigate and analyze large datasets more efficiently, reducing the challenges of traditional data processing.

The GLP-1 KG will integrate continuously updated EHRs and combine structured and unstructured data, including clinical notes, billing records, and lab results. Through a blend of machine learning and symbolic logic, the platform aims to identify patterns, treatment pathways, and complex relationships within datasets. This functionality enables precise assessments of pharmaceutical efficacy, patient outcomes, and treatment trends.

“Our integration with Microsoft empowers RespondHealth to deliver tailored, AI-driven analytics that meet the specific needs of any therapy for any client,” said Vicki Seyfert-Margolis, CEO and Founder of RespondHealth. “Rather than relying on generic, out-of-the-box models, we create custom tools to tackle today’s challenges and embrace future AI advancements. Microsoft Azure, with its secure, scalable platform, provides the foundation we need to deliver these innovations at scale, driving meaningful progress in healthcare analytics and patient outcomes.”

The GLP-1 KG also showcases the potential of neuro-symbolic reasoning, combining advanced statistical analysis with user-friendly interfaces. This innovation allows clinical, medical, and commercial teams to uncover actionable insights more efficiently, empowering healthcare stakeholders to make informed, evidence-based decisions.

“Each new development in AI inspires us to create tools that advance healthcare innovation,” added Seyfert-Margolis.